Search

everythinglearnresearchcommunity

for

Search:↓

People with androgenic alopecia (AGA) have a higher chance of getting metabolic syndrome.

The book explains causes and treatments for common hair loss, its psychological effects, related health risks, and emphasizes early screening and lifestyle changes.

Men with early-onset hair loss have a higher risk of metabolic syndrome.

Psoriasis, acne, and hair loss are linked to unhealthy cholesterol levels, increasing heart disease risk.

In Pakistan, men with more severe hair loss often have a higher BMI.

Men with early hair loss may have higher health risks similar to women with PCOS.

No link between hair loss and blood groups or Rhesus factor.

Men with genetic hair loss are more likely to have abnormal blood lipid levels, especially if the hair loss is severe.

Many men with male pattern baldness have abnormal blood fat levels, which may raise their risk of heart disease.

Men with common hair loss (AGA) are more likely to have metabolic syndrome, which increases heart disease risk. Early screening could help prevent heart disease. More research is needed to understand this relationship better.

Early balding in men is linked to metabolic syndrome, so screening is important for prevention.

PFS affects some women, steroids easily bought online, hypogonadism info unreliable, low testosterone linked to CVD.

AGA patients have higher rates of metabolic syndrome and carotid atheromatosis, suggesting early screening and prevention is important.

Prostaglandin E2 affects human platelet activity in complex ways that could lead to personalized heart disease treatments.

Scarring alopecia is linked to higher rates of vitamin D deficiency, metabolic issues, mental health problems, thyroid disease, and other health conditions.

There may be a link between hair loss and heart disease in women, but more research is needed.

Using too much topical minoxidil can cause serious side effects like dizziness and low blood pressure.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Cardiovascular disease deaths decreased but still caused one-third of U.S. deaths in 2007, with high rates of hypertension, smoking, obesity, and diabetes.

Potassium channel openers could help treat cardiovascular diseases and asthma but require better targeting to specific tissues for effective use.

Papain from papaya may help treat cardiovascular diseases by breaking down fibrin.

LDL apheresis lowers inflammation and cardiovascular risk by reducing CRP levels long-term.

Men with androgenetic alopecia may have higher cardiovascular risk due to elevated serum endocan levels.

Reproductive factors can increase hypertension risk and affect cardiovascular health.

FOL-026 peptide may help hair growth and cardiovascular health by improving blood flow and cell functions.

Detecting early breast arterial calcifications can help assess cardiovascular disease risk.

PCOS is linked to obesity and inflammation, increasing cardiovascular risk.